南华生物医药股份有限公司2025年第三次临时股东会决议公告

Meeting Overview - The shareholder meeting was held on September 22, 2025, with both on-site and online voting options available [3][4] - The meeting was convened by the company's 12th Board of Directors and presided over by Chairman Yang Yun [4] Attendance - A total of 366 shareholders attended the meeting, representing 175,062,605 shares, which accounts for 53.0456% of the company's voting shares [5][7] - Among these, 364 were small shareholders, representing 41,311,753 shares, or 12.5178% of the voting shares [8][10] Proposal Voting Results - The proposal to acquire equity in Loudi Jinhong New Materials Co., Ltd. through cash and capital increase was approved, with 154,186,756 shares in favor, representing 88.0752% of the valid votes [13] - Small shareholders voted 20,435,904 shares in favor, which is 49.4675% of their valid votes, while 50.5322% opposed the proposal [14] Legal Opinion - The legal opinion provided by Hunan Xiangjun Luhe Law Firm confirmed that the meeting's notice, convening, and voting procedures complied with relevant laws and regulations [15]